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Background  and purpose:  It remains  controversial  whether  Kawasaki  disease  (KD)  is  a  risk  factor  for  the
early  onset  of  atherosclerosis.
The  purpose  of  the  present  study  was  to  assess  endothelial  function  and  arterial  stiffness  as  markers
of  the  early  onset  of atherosclerosis  in adult  patients  with  a history  of KD.
Methods  and subjects:  We  compared  14  adult  patients  with  a history  of KD  with  41  healthy  controls.  To
assess  arterial  endothelial  function,  we  measured  the reactive  hyperemia-peripheral  arterial  tonometry
(RH-PAT)  index  and  augmentation  index adjusted  to  75  bpm  (AIx@75)  using  the Endo-PAT  2000  (Itamar
Medical,  Caesarea,  Israel).  In addition,  we  analyzed  medical  history,  blood  pressure,  lifestyle  habits,  and
atherosclerosis-related  serum  biochemical  markers  [asymmetric  dimethylarginine,  adiponectin,  lipopro-
tein (a), cholesterols,  atherogenic  index  of  plasma].
Results: There  was  no  difference  between  the  KD  and  control  groups  with  regard  to  the  RH-PAT  index
values  (2.10  ± 0.43  and  1.84  ± 0.49,  respectively;  p =  0.19).  However,  in the  KD  group, the  RH-PAT  index
values  were  negatively  correlated  with  the  febrile  period  in  the  acute  phase of  disease  (r2 = 0.458,
p  =  0.048).  In addition,  the  AIx@75  values  were  higher  in KD  patients  compared  to  healthy  controls
(−7.69  ±  11.86%  and  −15.87  ±  8.72%,  respectively;  p = 0.01).  No  signiﬁcant  differences  existed  between
the  KD and  control  groups  with  regard  to the serum  biomarkers  of atherosclerosis.
Conclusions:  We  speculate  that  endothelial  dysfunction  in former  KD patients  is  affected  by  the  febrile
period  of  the  acute  phase,  and  antiplatelet  drugs  may  improve  endothelial  function.  The  increased  arterial
stiffness  of  patients  caused  by post-inﬂammatory  ﬁbrotic  changes  in  the  arterial  wall  indicates  that  adults
 an in
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Kawasaki disease (KD) is acute systemic vasculitis that occurs
redominantly in infants and during early childhood. More than
2,000 individuals were newly diagnosed with KD in Japan in 2010
nd the average annual incidence rate was 222.9 per 100,000 chil-
ren aged 0–4 years in 2009–2010 [1]. As of 2006, the total number
f KD patients reported since 1970 was 225,682. Of those patients,
ore than 90,000 had already reached adulthood [2].
KD is typically self-limited, and a good prognosis is gener-
lly expected for patients who recover from KD without coronary
equelae. However, some studies have reported that some former
D patients without coronary artery lesions developed ischemic
∗ Corresponding author at: Department of Pediatrics and Adolescent Medicine,
untendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo
13-8421, Japan. Tel.: +81 3 3813 3111; fax: +81 3 5800 0216.
E-mail address: kentaka@juntendo.ac.jp (K. Takahashi).
914-5087/$ – see front matter © 2013 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2012.12.007creased  risk  of developing  atherosclerosis.
anese  College  of  Cardiology.  Published  by Elsevier  Ltd.  All  rights  reserved.
heart disease [3]. Therefore, a history of KD has recently been indi-
cated as a possible risk factor for the early onset of atherosclerosis.
Numerous reports have demonstrated the association between
KD and arteriosclerosis [4–13]. However, the studies primarily
investigated children or adolescents. Therefore, it remains contro-
versial whether KD is a risk factor for the onset of atherosclerosis
in adults.
Because endothelial dysfunction is closely related to arterioscle-
rosis risk factors [14–16], examination of endothelial function can
detect early-stage arteriosclerosis. The endothelium plays a crucial
role in the maintenance of vascular tone [17]. Endothelium-derived
nitric oxide (NO) is a potent endogenous vasodilator [18], which
is released in response to shear stress, and plays an important
role in ﬂow-mediated dilatation [19]. The functional assessment
of endothelial function is based on the physiological dilatation of
the artery in response to increased blood ﬂow [20].However, forearm ﬂow-mediated vasodilation (FMD) results
can vary due to technical problems. To evaluate endothelial
dysfunction, reactive hyperemia peripheral arterial tonometry
(RH-PAT) is conducted by measuring changes in the digital pulse
vier Ltd. All rights reserved.
 of Car
v
a
i
d
v
a
p
l
n
N
e
s
p
r
d
r
a
p
M
S
[
y
g
(
p
g
f
f
t
t
2
a
m
8
[
[
s
s
c
n
i
n
t
n
n
v
a
p
a
S
(
c
w
mH. Tobayama et al. / Journal
olume during reactive hyperemia; this technique is non-invasive,
utomatic, quantitative, and reproducible [21,22].
Another vascular alteration that precedes atherosclerosis is
ncreased rigidity of the arterial wall. Several indices have been
eveloped to assess arterial stiffness, including aortic pulse wave
elocity (PWV) and the augmentation index (AIx) [23,24]. AIx is
ssociated with cardiovascular risk [25], and is an independent
redictor of cardiovascular events [23].
In addition, the biochemical marker, asymmetric dimethy-
arginine (ADMA), acts as an endogenous inhibitor of endothelial
itric oxide synthase (NOS) by competing with l-arginine as a
OS substrate. ADMA reduces NO production, thereby leading to
ndothelial dysfunction and cardiovascular events. Studies have
hown that increased concentrations of ADMA found elevated
lasma ADMA concentration has been identiﬁed as an independent
isk factor for the progression of atherosclerosis and cardiovascular
eath [26,27].
To assess the long-term possibility of early-onset atheroscle-
osis after KD, we examined endothelial function using RH-PAT,
rterial stiffness using AIx, and biochemical markers in adult
atients late after the onset of KD.
aterials and methods
tudy subjects
This study included 14 adult patients referred to as the KD group
aged 21–41 years, mean ± standard deviation (SD): 31.5 ± 5.5
ears] and 41 age-matched subjects referred to as the control
roup. All subjects in both groups were Japanese, non-smokers
deﬁned as individuals who had never smoked), were not born
rematurely, and had no medical history of hypertension, hyper-
lycemia, or hypercholesterolemia. In addition, they did not have
amily histories of hereditary diseases such as homocystinuria or
amilial hypercholesterolemia. The KD group was recruited from
he Juntendo University Hospital, the Koshigaya Municipal Hospi-
al, and the Parents Association of Kawasaki Disease (interval time:
8.6 ± 5.6 years). Eleven of these patients had persistent coronary
neurysms, whereas one had aneurysms that had regressed. The
aximum diameter of the dilated coronary arteries was  more than
 mm in 5 patients [giant aneurysms (ANl)], 4–8 mm in 5 patients
medium aneurysms (ANm)], and less than 4 mm in 2 patients
small aneurysms (ANs) or dilatation (Dil)]. Four patients had local
tenosis (LS), 2 patients had mild coronary stenosis (one had 90%
tenotic lesion and the other had 75%), and 2 patients had moderate
oronary stenosis (they had 25%) [28]. Three of the KD patients did
ot have coronary complications. Three KD patients had received
ntravenous immunoglobulin therapy during the acute phase of ill-
ess, while 10 were also receiving long-term aspirin maintenance
herapy. One of the 10 subjects was taking clopidogrel as a mainte-
ance therapy. All the KD patients were asymptomatic and required
o coronary artery interventions. The control subjects were healthy
olunteers who  willingly participated in this study. This study was
pproved by the ethics committee of the Juntendo University Hos-
ital. Informed consent for the research protocol was obtained from
ll subjects.
tudy protocol
The subjects were advised against consuming food and drink
except for water) overnight, and against performing heavy exer-
ise on the day before the examination. Venous blood withdrawal
as performed in a quiet examination room at 23–26 ◦C in the early
orning.diology 61 (2013) 330–335 331
We obtained the past history for KD in all subjects, measured
blood pressure automatically from the right arm, and performed a
physical examination as described below. After the physical exam-
ination, blood analysis was  performed.
Assessment of endothelial function
RH-PAT was  performed using the Endo-PAT2000 method
(Itamar Medical Ltd., Cesarea, Israel), which assesses the magnitude
of RH at the ﬁnger-tip as a measure of microvascular endothelial
function. The participants were placed in the supine position with
both hands resting at the same level. Speciﬁc peripheral arterial
tonometry (PAT) ﬁnger probes for recording the digital pulse vol-
ume  curves (PAT signal) were placed on 1 ﬁnger of each hand and a
blood pressure cuff was placed on 1 upper arm (study arm), while
the other arm served as a control (control arm). After continuous
recording of the PAT signal from both hands for 10 min, the blood
pressure cuff on the study arm was inﬂated to whichever pres-
sure would be higher, i.e. 200 mm Hg or 60 mm Hg plus systolic
blood pressure for 5 min. Subsequently, the blood pressure cuff
was rapidly deﬂated to induce RH in the forearm and hand while
the PAT signal continued to be recorded for 10 min. The PAT sig-
nal data were analyzed automatically in an operator-independent
manner by the Endo-PAT2000 device. Brieﬂy, as a measure of the
extent of RH, the RH-PAT index was calculated as the ratio of the
average amplitude of the PAT signal over a 1-min time interval
starting 1 min  after cuff deﬂation divided by the average ampli-
tude of the PAT signal of the 3.5-min period before cuff inﬂation
(baseline), which was  then multiplied by a baseline correction
factor. The RH-PAT index values from the study arm were then
normalized to the control arm to compensate for potential sys-
temic changes. An RH-PAT index value less than or equal to 1.67
was used as a cut-off value to diagnose endothelial dysfunction
[29].
Assessment of arterial stiffness
Arterial stiffness was measured by AIx using PAT technology. AIx
is deﬁned as an increment in pressure after the ﬁrst systolic shoul-
der to the peak of aortic pressure and is expressed as a percentage
of aortic pulse pressure. Pressure sensors within this particular ﬁn-
ger probe capture the beat-by-beat ﬁnger pulse wave amplitude
(PWA), which is then ﬁltered, ampliﬁed, and graphically displayed
on a computer screen. A computerized algorithm was  generated to
automatically identify peak pressures and the inﬂection point. The
PAT-AIx is calculated by averaging the PWA  data over a period of
3.5 min, and is deﬁned as the difference between the second and
ﬁrst systolic peaks expressed as a percentage of the pulse pressure.
The AIx adjusted to 75 bpm (AIx@75) was calculated by adjusting
the AIx to a 75 beats/min variable, as this measurement is inﬂu-
enced by heart rate.
Blood sampling and analysis
Serum ADMA, adiponectin, lipoprotein (a), total cholesterol
(TC), high-density lipoprotein cholesterol (HDL-C), low-density
lipoprotein cholesterol (LDL-C), triglyceride (TG), glucose, and
insulin levels were evaluated. Using enzyme-linked immunosor-
bent assays (ELISA), we  measured ADMA and adiponectin (ADMA,
Immundiagnostik AG, Bensheim, Germany; adiponectin, Sek-
isui Medical, Tokyo, Japan). In addition, we  calculated the
homeostasis model assessment-insulin resistance (HOMA-IR)
as the level of glucose tolerance and the atherogenic index
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dilated lesions and the RH-PAT index values. However, in the KD
group, the RH-PAT index values were negatively correlated with the
febrile period in the acute phase of KD (r2 = 0.458, p = 0.048; Fig. 2).
Furthermore, 2 patients from the KD group who had long febrile
Table 3
Physiological characteristics and vascular function.
Patients (n = 14) Controls (n = 41) p-Value
Systolic blood pressure
(mm  Hg)
114.14 ± 14.1 112.39 ± 10.8 0.82
Diastolic blood
pressure (mm Hg)
75.14 ± 12.8 72.83 ± 9.85 0.67
Heart rate (bpm) 60.50 ± 6.16 61.44 ± 9.15 0.81
RH-PAT index 2.03 ± 0.44 1.89 ± 0.51 0.19
AIx@75 (%) −8.00 ± 11.54 −16.83 ± 8.28 0.01
Values are presented as mean ± SD. RH-PAT, reactive hyperemia-peripheral arterial32 H. Tobayama et al. / Journal
f plasma (AIP) as a marker of atherogenicity, as follows:
HOMA-IR = FIRI × FBG
405
AIP = log
[
TG
HDL
− C
]
Here, FIRI indicates fasting immunoreactive insulin (U/mL)
nd FBG, fasting blood sugar (mg/dL). We  measured ADMA as
n endothelial cell injury marker, lipoprotein (a) as a marker of
therosclerosis promotion, and adiponectin as an anti-atherogenic
arker.
tatistical analysis
All values are expressed as mean ± SD, unless otherwise spec-
ﬁed. All data analyses were performed using SPSS 17.0 software
SPSS, Chicago, IL, USA). For comparisons between the 2 groups,
tudent’s t-test (for parametric variables) or the Mann–Whitney U
est (for non-parametric variables) was performed. In the analy-
is of the clinical characteristics, the difference in proportions was
valuated using chi-square analysis. The relationship between arte-
ial function and the febrile period in the acute phase, the length of
he period before KD diagnosis, and markers of atherosclerosis were
valuated using Spearman’s rank-correlation coefﬁcient. A p-value
f less than 0.05 was considered statistically signiﬁcant.
esults
linical characteristicsThe clinical data are shown in Table 1. The patient characteristics
re shown in Table 2. No differences were observed between the
D group and the control group in terms of age, body weight, body
able 1
linical characteristics.
Patients (n = 14) Controls (n = 41) p-Value
Age (years) 31.5 ± 5.5 32.6 ± 5.3 0.56
Gender male 8 (57%) 21 (51%) 0.40
Body weight (kg) 58.2 ± 12.2 60.4 ± 11.8 0.38
Body height (cm) 164.0 ± 8.1 166.7 ± 7.7 0.24
BMI  21.5 ± 3.2 21.6 ± 3.0 0.92
Smoking 0 (0%) 0 (0%) 1
Born prematurely 0 (0%) 0 (0%) 1
Family medical history of
cardiovascular events
3 (21%) 16 (39%) 0.23
alues are presented as mean ± SD except number of subjects. BMI, body mass index.
able 2
atient characteristics.
Patients
Age at KD (years) 2.9 ± 3.1
Duration after KD (years) 28.6 ± 5.6
Febrile period (days) 16.9 ± 11.5
Treatment: IVIG Yes 3, no 8, unknown 3
Treatment: prednisolone Yes 3, no 8, unknown 3
Treatment: aspirin (acute phase) Yes 10, no 2, unknown 2
Abnormal ﬁndings of exercise ECG (chronic
phase)
Yes 0, no 10, unexamined 4
Coronary artery with dilatation lesion (Max) ANs or Dil 2, ANm 4, ANl 5
Coronary artery with stenotic lesion (Max) LS 4 (mild 2, moderate 2)
Antiplatelet agents 9 (64%)
Percutaneous coronary Intervention 0
Coronary artery bypass graft surgery 0
alues are presented as mean ± SD except number of subjects. KD, Kawasaki disease;
VIG, intravenous immunoglobulin therapy; ECG, electrocardiogram; ANs, small
neurysms; ANm, medium aneurysms; ANl, giant aneurysms; Dil, dilatation; LS,
ocal stenosis.diology 61 (2013) 330–335
height, body mass index (BMI), and blood pressure (Tables 1 and 3).
The HOMA-IR, AIP, TC, HDL-C, LDL-C, and TG values of the KD group
were all within normal limits and were not signiﬁcantly different
from those of the control group (Table 4).
Endothelial function
There was no difference between the KD group and the con-
trol group with regard to the RH-PAT index values (2.10 ± 0.43
and 1.84 ± 0.49, respectively; p = 0.19) (Fig. 1). There was no differ-
ence between patients treated with intravenous immunoglobulin
therapy (IVIG) and patients treated without IVIG (1.83 ± 0.23 and
2.20 ± 0.49, respectively; p = 0.28). There was  no statistically signif-
icant relationship between the maximum degree of the coronarytonometry; AIx@75, augmentation index adjusted to 75 bpm.
Table 4
Biochemical characteristics.
Patients (n = 14) Controls (n = 41) p-Value
ADMA (mol/l) 0.53 ± 0.12 0.51 ± 0.11 0.88
Total adiponectin (g/ml) 9.61 ± 7.79 7.48 ± 3.83 0.61
Lipoprotein(a) (mg/dl) 6.4 ± 6.1 6.3 ± 7.2 0.59
TC  (mg/dl) 182.5 ± 35.91 170.9 ± 29.56 0.54
HDL-C (mg/dl) 60.4 ± 10.1 62.1 ± 16.6 0.54
LDL-C (mg/dl) 107.6 ± 29.1 95.0 ± 23.9 0.27
TG  (mg/dl) 62.2 ± 36.2 83.7 ± 62.4 0.13
HOMA-IR 0.79 ± 0.41 0.65 ± 0.39 0.20
AIP  0.97 ± 0.13 1.04 ± 0.16 0.14
Values are presented as mean ± SD. ADMA, asymmetric dimethylarginine; TC,
total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density
lipoprotein cholesterol; TG, triglyceride; HOMA-IR, homeostasis model assessment-
insulin resistance; AIP, atherogenic index of plasma.
Fig. 1. Reactive hyperemia-peripheral arterial tonometry (RH-PAT) index in both
the  Kawasaki disease (KD) and control groups.
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dig. 2. Correlation between reactive hyperemia-peripheral arterial tonometry (RH-
AT) index and the febrile period in acute phase. The RH-PAT index values were
egatively correlated with the febrile period in acute phase of Kawasaki disease
r2 = −0.51, p = 0.046).
eriods showed abnormally lower RH-PAT index values. There was
o correlation between the RH-PAT values and the length of the
eriod before KD diagnosis.
rterial stiffness
The AIx@75 values were signiﬁcantly increased in the KD group
ompared to the control group (−7.69 ± 11.86% and −15.87 ± 8.72%,
espectively; p = 0.01) (Fig. 3). There were no correlations between
he AIx@75 value and the febrile period or the maximum degree of
he dilated coronary lesions.
arkers of atherosclerosis
There was no difference between the KD group and the con-
rol group with regard to the ADMA levels (0.53 ± 0.12 mol/l
nd 0.51 ± 0.11 mol/l, respectively; p = 0.88), lipoprotein (a) lev-
ls (6.4 ± 6.1 mg/dl and 6.3 ± 7.2 mg/dl, respectively; p = 0.59),
r adiponectin levels (9.61 ± 7.79 g/ml and 7.48 ± 3.83 g/ml,
espectively; p = 0.61). There were no correlations between those
arkers values and the febrile period or the maximum degree of
he dilated coronary lesions.
iscussionrterial stiffness
This study demonstrates that adults with a history of KD
ave increased arterial stiffness, as assessed by AIx@75 values, as
ig. 3. Augmentation index adjusted to 75 bpm (AIx@75) index in both the Kawasaki
isease (KD) and control groups.diology 61 (2013) 330–335 333
compared to age-and-gender-matched healthy individuals. Exces-
sive mechanical stretch of the arterial wall results in structural
alterations of the wall, including fraying and fracture of the elastic
lamellae, loss of muscle attachments, and increased collagen ﬁber
production. This leads to an increase in the arterial stiffness, which
is affected by aging and hypertension in particular [30–32].
There is substantial evidence indicating that arterial stiffness
is an independent risk factor for cardiovascular disease, as it is
observed in high-risk or community-based populations [33]. To
evaluate arterial stiffness, various methods have been developed.
Mitchell et al. [34] reported that higher aortic stiffness assessed by
PWV  was  associated with an increased risk of a ﬁrst cardiovascular
event in subjects whose mean age was  63 years. However, Weber
et al. [35] demonstrated that a higher AIx was associated with an
increased risk of coronary artery disease, particularly in younger
patients (up to 60 years of age). Furthermore, AIx values were
signiﬁcantly correlated with cardiovascular risk in asymptomatic
patients without a previous history of cardiovascular disease [25].
Therefore, AIx is considered a predictor of atherosclerotic cardio-
vascular disease in young adults or subjects without cardiovascular
disease.
In the present study, we  measured AIx by RH-PAT, which was
reported to correlate with cardiac risk factors, and to be a signif-
icant predictor of aortic systolic blood pressure [36]. Aortic blood
pressure is a predictor of cardiovascular events [25,37], and is a
better predictor of coronary artery sclerosis than brachial blood
pressure [38]. For adults who suffered from KD in childhood,
examinations such as coronary angiography, cardiac computed
tomography, cardiac magnetic resonance imaging, cardiac ultra-
sonography, exercise electrocardiograms, and cardiac scintigraphy
focus on the structure and blood supply of the coronary arteries.
However, vascular lesions occurring long after vasculitis due to KD
were observed not only in the coronary arteries but also in the sys-
tematic arteries [39]. Niboshi et al. [40] reported increased arterial
stiffness in adults long after KD using brachial–ankle PWV. Because
AIx is more useful in young adults or asymptomatic subjects with-
out cardiovascular disease as mentioned above, we used AIx to
assess arterial stiffness in young adults long after acute KD. The
present study demonstrated that adults who had previously had
KD had higher AIx@75 values than controls, whereas the mean age
and systolic blood pressure, which affect arterial stiffness, were not
statistically different between the KD and control groups. In the
acute phase of KD, dissociation and disruption of the internal elas-
tic lamina and edematous dissociation of the media are observed.
In the sub-acute phase, thickened intima and thinned media and
adventitia are diffusely replaced by ﬁbrous connective tissue [41].
Furthermore, Fujiwara et al. [42] indicated that even in patients
without coronary aneurysms, the maximal intimal thickness could
be abnormal, with angitis of the major coronary artery along with
the presence of inﬁltrating cells. Generally, the normal structure
of coronary arteries is destroyed by inﬂammatory cell inﬁltration,
leading to loss of elasticity of the vessel wall. Shirai et al. [43] exam-
ined coronary arteries in KD patients after intervals of more than
5 years after KD onset, and demonstrated distinct atherosclerotic
changes of the intimal lesions associated with de-differentiation
of smooth muscle cells. However, Takahashi et al. [44] reported
new intimal thickening, composed of ﬁbrotic tissue in the arteries
with no evidence of aneurysm formation. Therefore, although the
coronary arteries exhibiting new intimal thickening undergo scle-
rotic changes years after KD, these are post-inﬂammatory changes,
which are not the same as atherosclerotic changes. However, these
ﬁndings might suggest that these post-inﬂammatory structural
changes render the arteries vulnerable to arterial pressure. There-
fore, arterial stiffness increases in KD patients many years after
the acute phase of KD, which is also affected by age-related higher
arterial elasticity.
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ndothelial function
There was no difference between the KD and control groups with
egard to the endothelial function assessed by the RH-PAT index.
bnormal endothelial vasomotor function is the sign of early-
tage atherosclerosis [45]. Endothelial dysfunction is related to
ardiovascular events [16,46], and the same relationship has been
eported using the RH-PAT method [47]. Treatment can be initiated
efore the onset of atherosclerotic disease by assessing endothe-
ial function, resulting in the improvement of this index [48,49].
he RH-PAT method is useful because it is simple, noninvasive,
eproducible, and has low interobserver error [50]. Furthermore,
t appears that endogenous NO-mediated vasoregulation is par-
icularly prominent in the arteriovenous anastomoses in the
uman ﬁngertips [51]. Thus, RH-PAT is a reliable method for test-
ng endothelial function and is useful for detecting early-stage
therosclerosis.
The measurement of ultrasound-based FMD in the brachial
rtery has been widely used as a noninvasive method of assessing
ndothelial function. It was reported that there was a linear rela-
ionship between the PAT hyperemia ratio and FMD  during the
ame episode of reactive hyperemia in individuals with approx-
mately one-third reporting a history of coronary artery diseases
22]. In another study, the correlation between the PAT ratio and
MD  value was statistically signiﬁcant but moderate [52]. Hamburg
t al. [21] reported that the correlation between brachial and dig-
tal vascular function was observed only in older patients or those
ith more advanced vascular disease. It was speculated that this
eterogeneity may  be attributable to differences in endothelium-
ndependent vasodilator substances and physiological conditions
ased on vessel size.
In a previous study, the endothelial function in former KD
atients assessed by FMD  was signiﬁcantly lower than that of con-
rols [40]. Our apparently discordant ﬁndings may  be attributable
o 2 reasons. First, although endothelial dysfunction may  exist in
ormer KD patients, it might not be severe and may  present without
ny obvious history of atherosclerotic disease or elevation of serum
arkers. Second, although endothelial dysfunction as revealed by
mpaired RH-PAT index was present, we assume that the effect
f anti-platelet drugs in both acute phase and over the long term
ay  have inﬂuenced endothelial function in our study. Thus, our
esult indicating no association between the degree of the coronary
ilated lesions and the RH-PAT index values may  have been affected
y these drugs. The pathology results of the aneurysms of patients
reated with aspirin showed intact endothelium [53]. Furthermore,
nti-platelet drugs, such as aspirin and clopidogrel, are known to
mprove endothelial function [49,54–56]. In the present study, 64%
f our subjects were on anti-platelet therapy (aspirin or/and clopid-
grel). Niboshi et al. [40] reported that the incidence of medication
se (detailed information of the drugs was not shown) was  only
2.9%, which was far lower than that in our study. Therefore, we
ssume that anti-platelet drug therapy may  improve endothelial
unction. But the endothelial function was affected by the febrile
eriod in the acute phase of KD. Furthermore, 2 of our patients with
ong febrile periods, 28 and 35 days, showed abnormally lower RH-
AT index values (less than or equal to 1.67). Regardless of whether
nti-platelet drugs improve endothelial function, it is important to
uppress the inﬂammation promptly in KD patients.
In addition, our results indicated that IVIG treatment did not
ffect endothelial function. However, the number of subjects was
mall and the dosage and usage of immunoglobulin in this study
as not consistent among subjects. Therefore, there was  no statisti-
ally signiﬁcant difference detected between subjects who  received
nd did not receive immunoglobulin treatment.
Single administration of high-dose IVIG (2 g/kg) most effectively
uppresses KD-induced inﬂammation. Therefore, it is believed thatdiology 61 (2013) 330–335
endothelial function may  be improved in patients given a single
administration of high-dose IVIG (2 g/kg) compared to patients not
given IVIG. In a future study, we will compare the effects of high-
dose IVIG in larger sample sets.
In conclusion, young adults with a history of KD have increased
arterial stiffness as assessed by AIx relative to the control group.
Although endothelial dysfunction due to KD arteritis may not be
very severe, the RH-PAT index values were negatively correlated
with the febrile period in the acute phase of KD, and the subjects
with the longest febrile period had abnormal endothelial function.
Therefore, it is necessary to suppress inﬂammation in early-stage
KD with anti-platelet drugs such as aspirin and clopidogrel to
prevent the early onset of atherosclerosis. Furthermore, even in
adults with KD history without coronary sequelae, it may  be use-
ful to administer anti-platelet drugs to prevent the development of
atherosclerosis.
Study limitations
First, this study was  limited by the small sample size. Because
not all the patients received check-ups after the resolution of KD, it
was difﬁcult to recruit many adult former KD patients from a sin-
gle center. It is therefore important to investigate atherosclerosis
in young adults after KD in a multi-center trial. In future studies,
we would like to classify the KD group according to the treatment
regimens received in the acute phase and to assess the long-term
effects of these treatments. We  would also assess whether the dif-
ferences in coronary sequelae affect arterial function. Second, we
did not measure the plasma estrogen levels, which affect the RH-
PAT index values [57]. Although there were no female subjects who
were in the menstrual phase in the present study, it is necessary to
evaluate the inﬂuence of estrogen.
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